Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis

Jörgen Thorn; Björn Tilling; Karin Lisspers; Leif Jörgensen; Anna Stenling; Georgios Stratelis

doi:10.4104/pcrj.2011.00104

Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis

Primary Care Respiratory Journal ◽

10.4104/pcrj.2011.00104 ◽

2012 ◽

Vol 21 (2) ◽

pp. 159-166 ◽

Cited By ~ 25

Author(s):

Jörgen Thorn ◽

Björn Tilling ◽

Karin Lisspers ◽

Leif Jörgensen ◽

Anna Stenling ◽

...

Keyword(s):

Primary Care ◽

At Risk ◽

Cost Effectiveness ◽

Lung Function ◽

Real Life ◽

Cost Effectiveness Analysis ◽

Life Study ◽

Effectiveness Analysis ◽

Risk Patients ◽

Real Life Study

Download Full-text

PIH7 Cost-Effectiveness Analysis of Etonogestrel Contraceptive Implant Compared to SIX Other Contraceptive Methods Based on Real Life DATA in France

Value in Health ◽

10.1016/j.jval.2020.08.806 ◽

2020 ◽

Vol 23 ◽

pp. S539-S540

Author(s):

T. Linet ◽

L. Levy Bachelot ◽

G. Farge ◽

S. Crespi ◽

J.Z. Yang ◽

...

Keyword(s):

Cost Effectiveness ◽

Real Life ◽

Cost Effectiveness Analysis ◽

Contraceptive Methods ◽

Life Data ◽

Effectiveness Analysis ◽

Real Life Data ◽

Contraceptive Implant

Download Full-text

Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study

10.1183/13993003.congress-2021.pa478 ◽

2021 ◽

Author(s):

Eung Gu Lee ◽

Tae-Hee Lee ◽

Yujin Hong ◽

Jiwon Ryoo ◽

Jung Won Heo ◽

...

Keyword(s):

Lung Function ◽

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Low Dose ◽

Real Life ◽

Lung Function Decline ◽

Life Study ◽

Real Life Study

Download Full-text

PIN1 COST-EFFECTIVENESS ANALYSIS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE FOR HIGH RISK PATIENTS IN THE PERSPECTIVE OF BRAZILIAN NIP

Value in Health Regional Issues ◽

10.1016/j.vhri.2019.08.232 ◽

2019 ◽

Vol 19 ◽

pp. S40

Author(s):

R.F. Alexandre ◽

C. Salgado De Santana ◽

T. Senna ◽

J. Spinardi ◽

R. Sini

Keyword(s):

Cost Effectiveness ◽

High Risk ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Cost Effectiveness Analysis ◽

High Risk Patients ◽

Effectiveness Analysis ◽

Risk Patients

Download Full-text

Selecting optimal non-invasive cardiac imaging stress test in intermediate-risk patients using cost effectiveness analysis

European Heart Journal ◽

10.1093/eurheartj/ehl225 ◽

2006 ◽

Vol 27 (20) ◽

pp. 2378-2379 ◽

Cited By ~ 3

Author(s):

D. Poldermans ◽

J. J. Bax

Keyword(s):

Cost Effectiveness ◽

Cardiac Imaging ◽

Stress Test ◽

Cost Effectiveness Analysis ◽

Intermediate Risk ◽

Non Invasive ◽

Effectiveness Analysis ◽

Risk Patients

Download Full-text

A224 COST-EFFECTIVENESS ANALYSIS OF FECAL CALPROTECTIN USED IN PRIMARY CARE IN THE DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE

Journal of the Canadian Association of Gastroenterology ◽

10.1093/jcag/gwy009.224 ◽

2018 ◽

Vol 1 (suppl_2) ◽

pp. 332-332

Author(s):

M Chavannes ◽

C Wong ◽

T Mohammadi ◽

W Zhang ◽

G Rosenfeld

Keyword(s):

Primary Care ◽

Inflammatory Bowel Disease ◽

Cost Effectiveness ◽

Bowel Disease ◽

Fecal Calprotectin ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Inflammatory Bowel

Download Full-text

PRS21 COST-EFFECTIVENESS ANALYSIS OF XOLAIR UNDER REAL LIFE CONDITIONS IN BELGIAN PATIENTS WITH SEVERE ALLERGIC ASTHMA

Value in Health ◽

10.1016/s1098-3015(10)74483-1 ◽

2009 ◽

Vol 12 (7) ◽

pp. A302

Author(s):

P Lecomte ◽

CS Lee ◽

FE Van Nooten ◽

CL Thompson

Keyword(s):

Cost Effectiveness ◽

Allergic Asthma ◽

Real Life ◽

Cost Effectiveness Analysis ◽

Life Conditions ◽

Effectiveness Analysis ◽

Severe Allergic Asthma

Download Full-text

Economic Evaluation of Omalizumab in the Treatment of Severe AllergicAsthma in Adult Patients in Greece: A Cost Effectiveness Analysis ofClinical Trial and Real-Life Data

Pharmacoeconomics open access ◽

10.4172/2472-1042.1000103 ◽

2015 ◽

Vol 01 (01) ◽

Author(s):

Venkateshwarlu Sonathi

Keyword(s):

Economic Evaluation ◽

Cost Effectiveness ◽

Real Life ◽

Cost Effectiveness Analysis ◽

Adult Patients ◽

Life Data ◽

Effectiveness Analysis ◽

Real Life Data

Download Full-text

Screening for postnatal depression in primary care: cost effectiveness analysis

BMJ ◽

10.1136/bmj.b5203 ◽

2009 ◽

Vol 339 (dec22 1) ◽

pp. b5203-b5203 ◽

Cited By ~ 78

Author(s):

M. Paulden ◽

S. Palmer ◽

C. Hewitt ◽

S. Gilbody

Keyword(s):

Primary Care ◽

Cost Effectiveness ◽

Postnatal Depression ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

CP-061 Long-term cost-effectiveness analysis of infliximab, etanercept and adalimumab in rheumatoid arthritis patients in real-life clinical practice

European Journal of Hospital Pharmacy ◽

10.1136/ejhpharm-2015-000639.57 ◽

2015 ◽

Vol 22 (Suppl 1) ◽

pp. A24.1-A24

Author(s):

M Cardenas ◽

P Font ◽

S De La Fuente-Ruiz ◽

I Viguera-Guerra ◽

M Casado ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Cost Effectiveness ◽

Real Life ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the UK

Journal of Medical Economics ◽

10.3111/13696998.2015.1044456 ◽

2015 ◽

Vol 18 (9) ◽

pp. 746-761 ◽

Cited By ~ 21

Author(s):

G. Meier ◽

M. Gregg ◽

B. Poulsen Nautrup

Keyword(s):

At Risk ◽

Cost Effectiveness ◽

Influenza Vaccination ◽

The Elderly ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

The Uk

Download Full-text